LI
JANX icon

LRI Investments’s Janux Therapeutics JANX Stock Holding History

LRI Investments’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630 Hold
41
– – ﹤0.01% 1490
2026
Q1 		$570 Buy
+41
New +$562 ﹤0.01% 1360
2025
Q1 		– Sell
-92
Closed -$4.93K – 1233
2024
Q4 		$4.93K Hold
92
– – ﹤0.01% 937
2024
Q3 		$4.7K Buy
+92
New +$4K ﹤0.01% 950

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

LRI Investments's JANX Position: Q2 2026 in Review

LRI Investments held its Janux Therapeutics (JANX) position steady in Q2 2026 at 41 shares worth $630. The position accounts for ﹤0.01% of the portfolio, ranked #1490.

LRI Investments first reported a position in JANX in Q3 2024 and has held it in 4 quarters since. The position peaked at $4.93K in Q4 2024. 29 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • LRI Investments held 41 shares of Janux Therapeutics worth $630 as of Q2 2026.
  • LRI Investments left its Janux Therapeutics share count unchanged in Q2 2026.
  • Janux Therapeutics made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1490 holding.
  • LRI Investments first reported a position in Janux Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • LRI Investments's Janux Therapeutics position peaked at $4.93K in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.